mirror of
https://github.com/fkie-cad/nvd-json-data-feeds.git
synced 2025-05-28 09:11:28 +00:00
105 lines
3.0 KiB
JSON
105 lines
3.0 KiB
JSON
{
|
|
"id": "CVE-2007-6763",
|
|
"sourceIdentifier": "cve@mitre.org",
|
|
"published": "2019-07-31T18:15:10.753",
|
|
"lastModified": "2019-08-12T02:35:11.033",
|
|
"vulnStatus": "Analyzed",
|
|
"descriptions": [
|
|
{
|
|
"lang": "en",
|
|
"value": "SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser."
|
|
},
|
|
{
|
|
"lang": "es",
|
|
"value": "SAS Drug Development (SDD) anterior de 32DRG02 maneja mal las acciones de cierre de sesi\u00f3n, lo que permite a un usuario (que hab\u00eda iniciado sesi\u00f3n previamente) acceder a los recursos presionando un bot\u00f3n de retroceso o avance en un navegador web"
|
|
}
|
|
],
|
|
"metrics": {
|
|
"cvssMetricV30": [
|
|
{
|
|
"source": "nvd@nist.gov",
|
|
"type": "Primary",
|
|
"cvssData": {
|
|
"version": "3.0",
|
|
"vectorString": "CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H",
|
|
"attackVector": "NETWORK",
|
|
"attackComplexity": "LOW",
|
|
"privilegesRequired": "LOW",
|
|
"userInteraction": "NONE",
|
|
"scope": "UNCHANGED",
|
|
"confidentialityImpact": "HIGH",
|
|
"integrityImpact": "HIGH",
|
|
"availabilityImpact": "HIGH",
|
|
"baseScore": 8.8,
|
|
"baseSeverity": "HIGH"
|
|
},
|
|
"exploitabilityScore": 2.8,
|
|
"impactScore": 5.9
|
|
}
|
|
],
|
|
"cvssMetricV2": [
|
|
{
|
|
"source": "nvd@nist.gov",
|
|
"type": "Primary",
|
|
"cvssData": {
|
|
"version": "2.0",
|
|
"vectorString": "AV:N/AC:L/Au:S/C:P/I:P/A:P",
|
|
"accessVector": "NETWORK",
|
|
"accessComplexity": "LOW",
|
|
"authentication": "SINGLE",
|
|
"confidentialityImpact": "PARTIAL",
|
|
"integrityImpact": "PARTIAL",
|
|
"availabilityImpact": "PARTIAL",
|
|
"baseScore": 6.5
|
|
},
|
|
"baseSeverity": "MEDIUM",
|
|
"exploitabilityScore": 8.0,
|
|
"impactScore": 6.4,
|
|
"acInsufInfo": false,
|
|
"obtainAllPrivilege": false,
|
|
"obtainUserPrivilege": false,
|
|
"obtainOtherPrivilege": false,
|
|
"userInteractionRequired": false
|
|
}
|
|
]
|
|
},
|
|
"weaknesses": [
|
|
{
|
|
"source": "nvd@nist.gov",
|
|
"type": "Primary",
|
|
"description": [
|
|
{
|
|
"lang": "en",
|
|
"value": "CWE-20"
|
|
}
|
|
]
|
|
}
|
|
],
|
|
"configurations": [
|
|
{
|
|
"nodes": [
|
|
{
|
|
"operator": "OR",
|
|
"negate": false,
|
|
"cpeMatch": [
|
|
{
|
|
"vulnerable": true,
|
|
"criteria": "cpe:2.3:a:sas:sas_drug_development:*:*:*:*:*:*:*:*",
|
|
"versionEndExcluding": "32drg02",
|
|
"matchCriteriaId": "FCB9AF1A-F40F-441A-9B94-4955D92C9655"
|
|
}
|
|
]
|
|
}
|
|
]
|
|
}
|
|
],
|
|
"references": [
|
|
{
|
|
"url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf",
|
|
"source": "cve@mitre.org",
|
|
"tags": [
|
|
"Vendor Advisory"
|
|
]
|
|
}
|
|
]
|
|
} |